title: Panniculitis in Patients Undergoing Treatment With the Bruton Tyrosine Kinase Inhibitor Ibrutinib for Lymphoid Leukemias.
authors.affiliation: Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus.
authors.forename: Stephanie K
authors.initials: SK
authors.lastname: Fabbro
authors.affiliation: Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus.
authors.forename: Sabrina M
authors.initials: SM
authors.lastname: Smith
authors.affiliation: Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus.
authors.forename: Jason A
authors.initials: JA
authors.lastname: Dubovsky
authors.affiliation: Division of Dermatology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus3Department of Pathology, Ohio State University Wexner Medical Center, Columbus.
authors.forename: Alejandro A
authors.initials: AA
authors.lastname: Gru
authors.affiliation: Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Jones
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000328:Adult; D000077329:Agammaglobulinaemia Tyrosine Kinase; D000368:Aged; D000969:Antinematodal Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D015434:Panniculitis / Q000139:chemically induced* / Q000175:diagnosis; D010880:Piperidines; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011720:Pyrazoles / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000969:Antinematodal Agents; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D011505:Protein-Tyrosine Kinases; D000077329:Agammaglobulinaemia Tyrosine Kinase; D000225:Adenine